In contrast, the tumor suppressor gene TP53, largely mutated in different types of cancer, directly impairs glycolysis by downregulating GLUT1, GLUT4, and HK2 and favors oxidative phosphorylation (OXPHOS) (23). This evidence concerns the gene SLC2A1 and cancer.